A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers

Ira A. Katz, Anthony Harlan, Bresta Miranda-Palma, Luz Prieto-Sanchez, David G. Armstrong, John H. Bowker, Mark S. Mizel, Andrew J M Boulton

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

OBJECTIVE - The purpose of this study was to compare the effectiveness of a removable cast walker (RCW) rendered irremovable (iTCC) with the total contact cast (TCC) in the treatment of diabetic neuropathic plantar foot ulcers. RESEARCH DESIGN AND METHODS - In a prospective, randomized, controlled trial, 41 consecutive diabetic patients with chronic, nonischemic, neuropathic plantar foot ulcers were randomly assigned to one of two groups: a RCW rendered irremovable by wrapping it with a single layer of fiberglass casting material (i.e., an iTCC) or a standard TCC. Primary outcome measures were the proportion of patients with ulcers that healed at ≤ 12 weeks, healing rates, complication rates, cast placement/removal times, and costs. RESULTS - The proportions of patients with ulcers that healed within 12 weeks in the iTCC and TCC groups were 80 and 74%, respectively (94 and 93%, respectively, when patients who were lost to follow-up were excluded). Survival analysis (healing rates) was statistically equivalent in the two groups, as were complication rates, but with a trend toward benefit in the iTCC group. The iTCC took significantly less time to place and remove than the TCC with 39% and 36% reductions, respectively. There was also an overall lower cost associated with the use of the iTCC compared with the TCC. CONCLUSIONS - The iTCC may be equally efficacious, faster to place, easier to use, and less expensive than the TCC in the treatment of diabetic plantar neuropathic foot ulcers.

Original languageEnglish
Pages (from-to)555-559
Number of pages5
JournalDiabetes Care
Volume28
Issue number3
DOIs
StatePublished - Mar 1 2005

Fingerprint

Foot Ulcer
Diabetic Foot
Equipment and Supplies
Ulcer
Costs and Cost Analysis
Lost to Follow-Up
Survival Analysis
Research Design
Randomized Controlled Trials
Outcome Assessment (Health Care)
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Katz, I. A., Harlan, A., Miranda-Palma, B., Prieto-Sanchez, L., Armstrong, D. G., Bowker, J. H., ... Boulton, A. J. M. (2005). A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care, 28(3), 555-559. https://doi.org/10.2337/diacare.28.3.555

A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. / Katz, Ira A.; Harlan, Anthony; Miranda-Palma, Bresta; Prieto-Sanchez, Luz; Armstrong, David G.; Bowker, John H.; Mizel, Mark S.; Boulton, Andrew J M.

In: Diabetes Care, Vol. 28, No. 3, 01.03.2005, p. 555-559.

Research output: Contribution to journalArticle

Katz, IA, Harlan, A, Miranda-Palma, B, Prieto-Sanchez, L, Armstrong, DG, Bowker, JH, Mizel, MS & Boulton, AJM 2005, 'A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers', Diabetes Care, vol. 28, no. 3, pp. 555-559. https://doi.org/10.2337/diacare.28.3.555
Katz IA, Harlan A, Miranda-Palma B, Prieto-Sanchez L, Armstrong DG, Bowker JH et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care. 2005 Mar 1;28(3):555-559. https://doi.org/10.2337/diacare.28.3.555
Katz, Ira A. ; Harlan, Anthony ; Miranda-Palma, Bresta ; Prieto-Sanchez, Luz ; Armstrong, David G. ; Bowker, John H. ; Mizel, Mark S. ; Boulton, Andrew J M. / A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. In: Diabetes Care. 2005 ; Vol. 28, No. 3. pp. 555-559.
@article{1af2375277e24ba7ad408df98b0bc03b,
title = "A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers",
abstract = "OBJECTIVE - The purpose of this study was to compare the effectiveness of a removable cast walker (RCW) rendered irremovable (iTCC) with the total contact cast (TCC) in the treatment of diabetic neuropathic plantar foot ulcers. RESEARCH DESIGN AND METHODS - In a prospective, randomized, controlled trial, 41 consecutive diabetic patients with chronic, nonischemic, neuropathic plantar foot ulcers were randomly assigned to one of two groups: a RCW rendered irremovable by wrapping it with a single layer of fiberglass casting material (i.e., an iTCC) or a standard TCC. Primary outcome measures were the proportion of patients with ulcers that healed at ≤ 12 weeks, healing rates, complication rates, cast placement/removal times, and costs. RESULTS - The proportions of patients with ulcers that healed within 12 weeks in the iTCC and TCC groups were 80 and 74{\%}, respectively (94 and 93{\%}, respectively, when patients who were lost to follow-up were excluded). Survival analysis (healing rates) was statistically equivalent in the two groups, as were complication rates, but with a trend toward benefit in the iTCC group. The iTCC took significantly less time to place and remove than the TCC with 39{\%} and 36{\%} reductions, respectively. There was also an overall lower cost associated with the use of the iTCC compared with the TCC. CONCLUSIONS - The iTCC may be equally efficacious, faster to place, easier to use, and less expensive than the TCC in the treatment of diabetic plantar neuropathic foot ulcers.",
author = "Katz, {Ira A.} and Anthony Harlan and Bresta Miranda-Palma and Luz Prieto-Sanchez and Armstrong, {David G.} and Bowker, {John H.} and Mizel, {Mark S.} and Boulton, {Andrew J M}",
year = "2005",
month = "3",
day = "1",
doi = "10.2337/diacare.28.3.555",
language = "English",
volume = "28",
pages = "555--559",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers

AU - Katz, Ira A.

AU - Harlan, Anthony

AU - Miranda-Palma, Bresta

AU - Prieto-Sanchez, Luz

AU - Armstrong, David G.

AU - Bowker, John H.

AU - Mizel, Mark S.

AU - Boulton, Andrew J M

PY - 2005/3/1

Y1 - 2005/3/1

N2 - OBJECTIVE - The purpose of this study was to compare the effectiveness of a removable cast walker (RCW) rendered irremovable (iTCC) with the total contact cast (TCC) in the treatment of diabetic neuropathic plantar foot ulcers. RESEARCH DESIGN AND METHODS - In a prospective, randomized, controlled trial, 41 consecutive diabetic patients with chronic, nonischemic, neuropathic plantar foot ulcers were randomly assigned to one of two groups: a RCW rendered irremovable by wrapping it with a single layer of fiberglass casting material (i.e., an iTCC) or a standard TCC. Primary outcome measures were the proportion of patients with ulcers that healed at ≤ 12 weeks, healing rates, complication rates, cast placement/removal times, and costs. RESULTS - The proportions of patients with ulcers that healed within 12 weeks in the iTCC and TCC groups were 80 and 74%, respectively (94 and 93%, respectively, when patients who were lost to follow-up were excluded). Survival analysis (healing rates) was statistically equivalent in the two groups, as were complication rates, but with a trend toward benefit in the iTCC group. The iTCC took significantly less time to place and remove than the TCC with 39% and 36% reductions, respectively. There was also an overall lower cost associated with the use of the iTCC compared with the TCC. CONCLUSIONS - The iTCC may be equally efficacious, faster to place, easier to use, and less expensive than the TCC in the treatment of diabetic plantar neuropathic foot ulcers.

AB - OBJECTIVE - The purpose of this study was to compare the effectiveness of a removable cast walker (RCW) rendered irremovable (iTCC) with the total contact cast (TCC) in the treatment of diabetic neuropathic plantar foot ulcers. RESEARCH DESIGN AND METHODS - In a prospective, randomized, controlled trial, 41 consecutive diabetic patients with chronic, nonischemic, neuropathic plantar foot ulcers were randomly assigned to one of two groups: a RCW rendered irremovable by wrapping it with a single layer of fiberglass casting material (i.e., an iTCC) or a standard TCC. Primary outcome measures were the proportion of patients with ulcers that healed at ≤ 12 weeks, healing rates, complication rates, cast placement/removal times, and costs. RESULTS - The proportions of patients with ulcers that healed within 12 weeks in the iTCC and TCC groups were 80 and 74%, respectively (94 and 93%, respectively, when patients who were lost to follow-up were excluded). Survival analysis (healing rates) was statistically equivalent in the two groups, as were complication rates, but with a trend toward benefit in the iTCC group. The iTCC took significantly less time to place and remove than the TCC with 39% and 36% reductions, respectively. There was also an overall lower cost associated with the use of the iTCC compared with the TCC. CONCLUSIONS - The iTCC may be equally efficacious, faster to place, easier to use, and less expensive than the TCC in the treatment of diabetic plantar neuropathic foot ulcers.

UR - http://www.scopus.com/inward/record.url?scp=14644419573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644419573&partnerID=8YFLogxK

U2 - 10.2337/diacare.28.3.555

DO - 10.2337/diacare.28.3.555

M3 - Article

VL - 28

SP - 555

EP - 559

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 3

ER -